USPTO serial 79410507
URSAPHARM
Reviewed by CopyMark Law Group
Status 661
- Filing date
- Status date
- Registration date
- —
- Examiner
- ALI, STEPHANIE MARIE
- Law office
- TMEG LAW OFFICE 109
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with URSAPHARM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ellen A. Andelman
Ellen A. Andelman Moore & Van Allen PLLC100 North Tryon StreetSuite 4700Charlotte, NC 28202-4003Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Non-medicated cosmetics, namely, non-medicated skin care preparations, non-medicated skin care lotions, non-medicated skin care creams, non-medicated skin care oils, non-medicated moisturizing hand lotions, non-medicated skin care preparations and serums for cosmetic purposes, for protection against sunburns, non-medicated skin care preparations and serums for cosmetic purposes for protection against ultraviolet radiation, blue light and infrared radiation, non-medicated skin care preparations and serums for cosmetic purposes for reducing pigmentation spots, cosmetic creams for skin care, wrinkle removing skin care preparations, eye creams, eye gel, eye lotions, eye compresses for cosmetic purposes, gel eye patches for cosmetic purposes, cosmetic creams for firming skin around eyes, non-medicated eye-wash, namely, spray for eyelid hygiene, tissues impregnated with cosmetics lotions, wipes impregnated with a skin cleanser, pre-moistened cosmetic wipes | ACTIVE | — |
| 005 | pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical products for ophthalmological use; pharmaceutical products for ophthalmological use, namely, lubricating eye drops and ointments; medical preparations, namely, topical gel and nasal spray for the prevention and treatment of cold and flu; medical preparations, namely, saline solutions and pills for the treatment of swellings in the nasal passage and of the nasal mucosa; medical preparations, namely, nasal drops for the treatment of allergies; medical preparations, namely, nose spray for the treatment of virus infections; pharmaceutical products and preparations to prevent swelling in the legs; dietetic preparations adapted for medical purposes, namely, pills and capsules for the treatment of nutritious deficiencies, namely, vitamin deficiencies, iron deficiencies, zinc deficiencies; medical preparations for the treatment of acute, injury-induced swelling or swelling caused by surgical incision, in particular dental surgery and cosmetic procedures; medicated creams for treating dermatological conditions; dietary and nutritional supplements; dietary supplements consisting primarily of zinc, iron, omega-3 fatty acids; contact lens cleaning preparations; solutions for contact lenses; solutions for rinsing contact lenses; disinfectants for contact lenses; contact lens wetting solutions; solutions for neutralizing contact lenses; eye compresses | ACTIVE | — |
| 010 | Containers with dosing devices for dispensing pharmaceuticals, namely, eye droppers, therapeutic devices, namely, chemically-heated eye masks to provide relief from dry eyes and for the treatment of blepharitis; chemically activated hot and/or cold compresses | ACTIVE | — |
| 035 | Wholesale and retail store services, including online wholesale and retail store services, featuring non-medicated cosmetics and toiletry preparations; wholesale and retail store services, including online wholesale and retail store services, featuring pharmaceutical and medical preparations, namely, ophthalmological preparations, in particular lubricating eye drops and lubricating eye ointments, pharmaceuticals and medical preparations for the treatment of colds, allergies, acute swelling, venous disorders, namely, varicose veins and spider veins, nutritious deficiencies, namely, vitamin deficiencies, iron deficiencies, zinc deficiencies, trace element deficiencies, anemia and digestive disorders, medicated creams for skin care and for treating dermatological conditions, medicated skin care preparations for treating, reducing and preventing lines, pores, and loss of skin firmness; wholesale and retail store services, including online wholesale and retail store services, featuring dietetic foodstuffs and substances for medical purposes, namely, dietetic substances consisting of vitamins, minerals, amino acids and trace elements, dietary supplements for humans for the support of the eyesight, dietary supplements for humans for the support of the immune system; wholesale and retail store services, including online wholesale and retail store services, featuring cleaning preparations for contact lenses, solutions for use with contact lenses, rinsing solutions for contact lenses, contact lens disinfectants, moisturising solutions for contact lenses, solutions for neutralizing contact lenses; wholesale and retail store services, including online wholesale and retail store services, featuring medicated creams for the treatment of ophthalmological conditions, diseases and disorders, medicated creams for moisturizing the skin, pharmaceutical creams for the treatment of ophthalmological conditions, diseases and disorders; wholesale and retail store services, including online wholesale and retail store services, featuring eye compresses, containers with dosing devices for dispensing pharmaceuticals, namely, dosing containers for eye drops; wholesale and retail store services, including online wholesale and retail store services, featuring medical apparatus and instruments, namely, warming eye masks for the treatment of ophthalmologic disorders and conditions, chemically activated hot compresses for the treatment of ophthalmologic disorders and conditions; wholesale and retail store services, including online wholesale and retail store services, featuring data processing apparatus for recording information about the frequency of administration and dosage of medicines; wholesale and retail store services, including online wholesale and retail store services, featuring computer software for controlling and managing patient medical information, downloadable mobile software applications for controlling and managing patient medical information; promotion of goods and services through sponsorship | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 12, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 12, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 12, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 7, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 20, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 20, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 15, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 15, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 15, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 5, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 5, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 5, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Dec 5, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 19, 2025 | RFNP | REFUSAL PROCESSED BY IB | — |
| Jun 28, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 28, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 8, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 29, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 28, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 25, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 25, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 25, 2024 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Nov 21, 2024 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |